Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil. In a statement ...

Teva has said it disagrees with the verdict ... that prevented cheaper generic competition for its sleep disorder drug Provigil (modafinil). It was also named as one of the companies involved ...